News

GSK To Pour $30 Billion Into US R&D, Manufacturing Over Five Years

GSK will invest $30 billion in U.S. R&D and manufacturing, including a new biologics factory, AI upgrades, and expanded drug ...

GSK adding a biologics factory in Upper Merion as part of a $1.2 billion investment in the U.S.

The new projects, including AI efforts in Pennsylvania and three other states, are part of the British firm's pledge to ...
Fierce Pharma

Seeking royalties, GSK expands mRNA patent litigation to include Moderna's next-generation COVID shot

A little less than a year after targeting Moderna in an mRNA vaccine patent lawsuit, GSK is widening the scope of its ...
Devdiscourse

GSK Unveils $30 Billion U.S. Investment to Boost Life Sciences and Manufacturing

GSK has announced a $30 billion investment in the U.S. over five years to enhance R&D and manufacturing, focusing on ...
Analytics Insight

FTSE 100 Live: Microsoft and GSK Unveil $30 Billion Investments, FTSE 100 Steadies as Investors Await Fed Decision

The FTSE 100 recovered ground on Wednesday, supported by gains in utilities and housebuilders, even as mining stocks lagged.
Cantech Letter

GSK’s RSV Vaccine Arexvy Included in Publicly Funded Prevention Programs for Older Adults in Canada

GSK announced today that Arexvy (respiratory syncytial virus vaccine – recombinant, AS01E adjuvanted) will be offered through ...